Hlíf Steingrímsdóttir

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Ulf‐Henrik Mellqvist, Peter Gimsing, Øyvind Hjertner et al. · Blood · 2013 · 143 citations · Full text

Medicine, Hematology, Oncology +17

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

Sæmundur Rögnvaldsson, Þorvarður Jón Löve, Sigrún Þorsteinsdóttir et al. · Blood Cancer Journal · 2021 · 119 citations · Full text

Medicine, Internal Medicine, Oncology +13

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

Þórir Einarsson Long, Ólafur S. Indridason, Runólfur Pálsson et al. · Blood Cancer Journal · 2022 · 117 citations · Full text

Medicine, Nephrology, Renal Pathology +16

Bioavailability of Aciclovir after Oral Administration of Aciclovir and Its Prodrug Valaciclovir to Patients with Leukopenia after Chemotherapy

Hlíf Steingrímsdóttir, Astrid Gruber, Carina Palm et al. · Antimicrobial Agents and Chemotherapy · 2000 · 66 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study

Sigrún Þorsteinsdóttir, Sigrún H. Lund, Ebba K. Lindqvist et al. · Blood Advances · 2017 · 34 citations · Full text

Medicine, Orthopedic Surgery, Bone Metabolism +12